When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Emerging victorious in a bidding joust with AcelRx Pharmaceuticals (NASDAQ:ACRX), Melinta Therapeutics (NASDAQ:MLNT) enters into a definitive merger agreement with Tetraphase Pharmaceuticals (NASDAQ:TTPH) under which it will acquire the company for $39M in cash plus an additional $16M payable under contingent value rights.
More news on: AcelRx Pharmaceuticals, Inc., Melinta Therapeutics, Inc., Tetraphase Pharmaceuticals, Inc., Healthcare stocks news, Merger & acquisition news, Stocks on the move,